期刊文献+

诊断儿童药物性肝损伤应重视除外遗传代谢性肝病 被引量:5

Attention is paid to exclusion of genetic-metabolic liver disease in diagnosis of childhood drug-induced liver injury
原文传递
导出
摘要 药物性肝损伤是儿童非感染性肝病中的常见病,但缺乏特异性的诊断方法。遗传代谢性肝病属于罕见病,社会认知度低,需要特殊检查才能确诊。两类疾病临床表现类似,复杂多样,易将遗传代谢性肝病误诊为药物性肝损伤。临床上需提高认识,在诊断药物性肝损伤中注意除外遗传代谢性肝病,以免误诊。 Drug-induced liver injury(DILI)is a common disease in children with non-infectious liver di-seases,but there is no specific diagnostic method.Genetic-metabolic liver disease is a rare disease with low social recognition and requiring special examination to be diagnosed.The clinical manifestations of the 2 diseases are similar and complex,so it is easy to misdiagnose genetic-metabolic liver disease as DILI.In clinical practice,it is necessary to raise the awareness of excluding genetic-metabolic liver diseases in the diagnosis of DILI,so as to avoid misdiagnosis.
作者 朱世殊 董漪 Zhu Shishu;Dong Yi(Adolescent Liver Disease Center,the 5th Medical Center,PLA General Hospital,Beijing 100039,China)
出处 《中华实用儿科临床杂志》 CSCD 北大核心 2020年第9期653-655,共3页 Chinese Journal of Applied Clinical Pediatrics
关键词 药物性肝损伤 遗传代谢性肝病 临床表现 诊断 Drug-induced liver injury Genetic-metabolic liver disease Clinical manifestations Diagnosis
  • 相关文献

参考文献14

二级参考文献150

共引文献659

同被引文献57

引证文献5

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部